Randomized Controlled Study to Compare Efficacy of Aspirin 75mg and 150mg In the Prevention of Preeclampsia In High Risk Pregnant Women

Starting soon · Phase 4

Conditions studied: Pregnancy Induced Hypertension (PIH)

In brief

Preeclampsia in pregnancy is a dreaded complication which has both fetal and maternal adverse outcomes. Studies and WHO have advocated that this complication can be prevented by Aspirin. However which dose is more effective in preventing preeclampsia, whether 75mg or 150mg, will be known from this study.

Key facts

Study ID

NCT07373756

Run by

Dr. Sunita Pun

People needed

86

Starts

2026-01-15

Expected to finish

2026-12-31

Last updated by the study team

2026-01-28

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• • All pregnant women with Gestosis score of 3 or more who consents for the study and aged 18 years and above.

You may not qualify if…

• • Known hypersensitivity to aspirin, uncontrolled asthma with NSAID sensitivity
• Bleeding disorders, platelet dysfunction, thrombocytopenia, anticoagulant use, active peptic ulcer, history of GI bleed, severe hepatic/ renal disease

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.